Maximizing the clinical benefit of novel therapies in multiple myeloma
Oncology (Williston Park)
.
2009 Apr 30;23(5):415-6, 419.
Authors
Jacob Laubach
1
,
Constantine Mitsiades
,
Kenneth Anderson
,
Paul Richardson
Affiliation
1
Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
PMID:
19476274
No abstract available
Publication types
Comment
Review
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Clinical Trials as Topic
Humans
Multiple Myeloma / therapy*
Stem Cell Transplantation